Type 2 diabetes drug launches
RecordSTO-X8M04DZ4A1-P892TV93P7-6ZFKA6
China · 2025
Type 2 diabetes drug launches in China were 6 in 2025 (DIA).
Type 2 diabetes drug launches: every country and year, and how it is measured
- Publisher
- DIA
- Authority tier
- T2 Official
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Among them, six new drugs were launched for type 2 diabetes (T2D), including the DPP-4 inhibitor prusogliptin, the anti-CD3 biologic teplizumab, the GLP-1R agonist efsubaglutide α, as well as the combination therapies retagliptin + henagliflozin + metformin and retagliptin + metformin.
Checked: the figure 6is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6
Other formats: MLA, Chicago, BibTeX
- MLA
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025, https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6.
- Chicago
- DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025. https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6.
- BibTeX
- @misc{dia2025type6zfka6, author = {{DIA}}, title = {2025 NMPA Approvals: China Clears Record Number of New Drugs}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_X8M04DZ4A1P892TV93P76ZFKA6}, note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- DIA · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- 2025 NMPA Approvals: China Clears Record Number of New Drugs
- Type
- Press release
- Published
- —
- Locator
- The Cancer Sector Continues to Attract the Most Players
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_X8M04DZ4A1P892TV93P76ZFKA6